Literature DB >> 14980671

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors.

Zhaozhong J Jia1, Yanhong Wu, Wenrong Huang, Penglie Zhang, Yonghong Song, John Woolfrey, Uma Sinha, Ann E Arfsten, Susan T Edwards, Athiwat Hutchaleelaha, Stanley J Hollennbach, Joseph L Lambing, Robert M Scarborough, Bing-Yan Zhu.   

Abstract

Using N,N-dialkylated benzamidines as the novel P4 motifs, we have designed and synthesized a class of 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides as highly potent and selective fXa inhibitors with significantly improved hydrophilicity and in vitro anticoagulant activity. These benzamidine-P4 fXa inhibitors have displayed excellent oral bioavailability and long half-life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980671     DOI: 10.1016/j.bmcl.2003.12.054

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors.

Authors:  Katerina Capková; Yoshiyuki Yoneda; Tobin J Dickerson; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2007-10-09       Impact factor: 2.823

2.  1-[(6-Chloro-3-pyrid-yl)meth-yl]-N-(4-ethoxy-phen-yl)-3-phenyl-1H-pyrazole-5-carboxamide.

Authors:  Zheng Tang; Xiao-Liang Ding; Wen-Liang Dong; Bao-Xiang Zhao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-25

3.  4-(1,3-Diphenyl-4,5-dihydro-1H-pyrazol-5-yl)-1,3-diphenyl-1H-pyrazole.

Authors:  Hoong-Kun Fun; Tze Shyang Chia; Shridhar Malladi; Arun M Isloor; Kammasandra N Shivananda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-05

4.  Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers.

Authors:  Chao Wang; Yuelin Li; Zi Liu; Zeyu Wang; Zihan Liu; Shuai Man; Yujing Zhang; Kai Bao; Yingliang Wu; Qi Guan; Daiying Zuo; Weige Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.